Clinical trial · Observational
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
Assessing Benefits and Harms of Cannabis Use in Patients Treated With Immunotherapy for Cancer: a Prospective Cohort Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research is to assess how patients with cancer being treated with Immune Checkpoint Inhibitors (ICI) manage symptoms related to cancer and/or its treatment. Patients use a variety of ways to manage symptoms including traditional and alternative treatments including cannabis, acupuncture, etc. This research will have an important impact on our knowledge of cancer symptom management, and ultimately improve patient care and safety. Participants will complete online surveys and 7 days of ecological momentary assessments at 0, 1, 2, 4, 6, 9 and 12 month to compare the cannabis users and non cannabis users symptoms.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Cannabis User
- description
- Cancer patients being treated with immunotherapy and using cannabis
- label
- Cannabis non-user
- description
- Cancer patients being treated with immunotherapy and not using cannabis
Primary outcomes (8)
- measure
- Patient Reported Outcomes Measurement Information System: Pain interference
- timeFrame
- 0,1,2,4,6,9 and 12 months
- description
- Pain interference with daily life and enjoyment on a 5 item scale of not at all to very much. Higher score indicates worse outcome.
- measure
- Patient Reported Outcomes Measurement Information System: Sleep
- timeFrame
- 0,1,2,4,6,9 and 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * adult age of 18 years or older * cancer diagnosis and planning or using immunotherapy treatment, * pain and spend less than 50% in bed or chair * fluent in english language Exclusion Criteria: * use synthetic cannabis or only use Cannabidiol (CBD) * non users but used in the past 3 months * Patients receiving immunosuppressants or organ transplant recipients. * Patients within 6 months of Hospice care. * Pain that limits movement to more than 50% of their day in bed or chair
References
Publications (0)
Data not yet available